APYX MEDICAL CORP (APYX) Stock Analyst Earnings Estimates
NASDAQ:APYX - Nasdaq - US03837C1062 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 44.51M -8.26% | 52.349M 17.61% | 48.102M -8.11% | 49.183M 2.25% | 52.51M 6.76% | 57.834M 10.14% | 71.987M 24.47% | 272.59M 278.67% | 361.19M 32.50% | |
| EBITDA YoY % growth | -22.67M -67.31% | -19.259M 15.05% | -18.246M 5.26% | -6.904M 62.16% | -8.856M -28.27% | -6.12M 30.89% | 14.178M 331.67% | N/A | N/A | |
| EBIT YoY % growth | -23.56M -63.04% | -19.951M 15.32% | -18.845M 5.54% | -10.649M 43.49% | -13.416M -25.98% | -11.934M 11.05% | 1.799M 115.07% | 40.889M 2,172.87% | 72.237M 76.67% | |
| Operating Margin | -52.93% | -38.11% | -39.18% | -21.65% | -25.55% | -20.63% | 2.50% | 15.00% | 20.00% | |
| EPS YoY % growth | -0.67 -52.27% | -0.62 7.46% | -0.67 -8.06% | -0.37 45.19% | -0.44 -19.44% | -0.34 23.26% | -0.03 90.91% | N/A | N/A |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.10 49.90% | -0.10 29.57% | -0.08 34.83% | -0.12 -22.40% | -0.09 4.64% | -0.08 14.14% | -0.09 -21.30% |
| Revenue Q2Q % growth | 11.933M -1.78% | 11.97M 4.20% | 15.682M 10.27% | 10.388M 10.16% | 13.648M 14.37% | 12.893M 7.71% | 15.142M -3.44% |
| EBITDA Q2Q % growth | -1.715M 67.23% | -1.832M 42.36% | -888.42K 63.72% | -3.49M -19.82% | N/A | N/A | N/A |
| EBIT Q2Q % growth | -2.664M 51.97% | -2.858M 21.39% | -2.042M 33.02% | -4.478M -46.76% | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.10 54.55% | -0.12 | 0.02 | 18.30% |
| Q4 2024 Q2Q % growth | -0.12 57.14% | -0.16 | 0.04 | 26.47% |
| Q3 2024 Q2Q % growth | -0.14 -7.69% | -0.19 | 0.05 | 26.05% |
| Q2 2024 Q2Q % growth | -0.19 -72.73% | -0.20 | 0.01 | 6.02% |
| Q1 2024 Q2Q % growth | -0.22 -120.00% | -0.22 | 0.00 | -0.60% |
| Q4 2023 Q2Q % growth | -0.28 -64.71% | -0.18 | -0.10 | -54.57% |
| Q3 2023 Q2Q % growth | -0.13 23.53% | -0.12 | -0.01 | -12.59% |
| Q2 2023 Q2Q % growth | -0.11 31.25% | -0.07 | -0.04 | -55.39% |
| Q1 2023 Q2Q % growth | -0.10 41.18% | -0.14 | 0.04 | 27.38% |
| Q4 2022 Q2Q % growth | -0.17 -183.33% | -0.15 | -0.02 | -16.96% |
| Q3 2022 Q2Q % growth | -0.17 -41.67% | -0.15 | -0.02 | -14.94% |
| Q2 2022 Q2Q % growth | -0.16 -33.33% | -0.19 | 0.03 | 16.34% |
| Q1 2022 Q2Q % growth | -0.17 -21.43% | -0.15 | -0.02 | -13.63% |
| Q4 2021 Q2Q % growth | -0.06 -50.00% | -0.11 | 0.05 | 46.52% |
| Q3 2021 Q2Q % growth | -0.12 -9.09% | -0.15 | 0.03 | 21.57% |
| Q2 2021 Q2Q % growth | -0.12 14.29% | -0.15 | 0.03 | 20.10% |
| Q1 2021 Q2Q % growth | -0.14 30.00% | -0.15 | 0.01 | 3.68% |
| Q4 2020 Q2Q % growth | -0.04 75.00% | -0.11 | 0.07 | 64.99% |
| Q3 2020 Q2Q % growth | -0.11 15.38% | -0.17 | 0.06 | 34.74% |
| Q2 2020 Q2Q % growth | -0.14 -7.69% | -0.22 | 0.08 | 35.41% |
| Q1 2020 Q2Q % growth | -0.20 -42.86% | -0.26 | 0.05 | 21.57% |
| Q4 2019 Q2Q % growth | -0.16 | -0.20 | 0.04 | 18.83% |
| Q3 2019 Q2Q % growth | -0.13 | -0.18 | 0.05 | 29.19% |
| Q2 2019 Q2Q % growth | -0.13 | -0.18 | 0.05 | 29.19% |
| Q1 2019 Q2Q % growth | -0.14 | -0.18 | 0.04 | 23.75% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 9.43M -7.95% | 9.576M | -146K | -1.52% |
| Q4 2024 Q2Q % growth | 14.222M -3.00% | 13.656M | 566K | 4.14% |
| Q3 2024 Q2Q % growth | 11.487M -4.08% | 11.606M | -119K | -1.03% |
| Q2 2024 Q2Q % growth | 12.149M -10.47% | 11.982M | 167K | 1.39% |
| Q1 2024 Q2Q % growth | 10.244M -15.63% | 9.717M | 527K | 5.42% |
| Q4 2023 Q2Q % growth | 14.662M 16.27% | 15.145M | -483K | -3.19% |
| Q3 2023 Q2Q % growth | 11.976M 31.46% | 15.678M | -3.702M | -23.61% |
| Q2 2023 Q2Q % growth | 13.569M 31.87% | 14.612M | -1.043M | -7.14% |
| Q1 2023 Q2Q % growth | 12.142M -2.79% | 11.084M | 1.058M | 9.55% |
| Q4 2022 Q2Q % growth | 12.61M -25.03% | 13.195M | -585K | -4.43% |
| Q3 2022 Q2Q % growth | 9.11M -22.99% | 12.25M | -3.14M | -25.63% |
| Q2 2022 Q2Q % growth | 10.29M -8.29% | 10.768M | -478K | -4.44% |
| Q1 2022 Q2Q % growth | 12.49M 44.56% | 11.345M | 1.145M | 10.09% |
| Q4 2021 Q2Q % growth | 16.82M 46.77% | 14.919M | 1.901M | 12.74% |
| Q3 2021 Q2Q % growth | 11.83M 70.22% | 10.4M | 1.43M | 13.75% |
| Q2 2021 Q2Q % growth | 11.22M 160.93% | 9.039M | 2.181M | 24.13% |
| Q1 2021 Q2Q % growth | 8.64M 72.80% | 8.375M | 265K | 3.16% |
| Q4 2020 Q2Q % growth | 11.46M 35.46% | 9.808M | 1.652M | 16.84% |
| Q3 2020 Q2Q % growth | 6.95M -8.31% | 5.797M | 1.153M | 19.89% |
| Q2 2020 Q2Q % growth | 4.3M -35.34% | 2.004M | 2.296M | 114.57% |
| Q1 2020 Q2Q % growth | 5M -11.19% | 5.305M | -305K | -5.75% |
| Q4 2019 Q2Q % growth | 8.46M | 8.014M | 446K | 5.57% |
| Q3 2019 Q2Q % growth | 7.58M | 6.918M | 662K | 9.57% |
| Q2 2019 Q2Q % growth | 6.65M | 5.986M | 664K | 11.09% |
| Q1 2019 Q2Q % growth | 5.63M | 5.785M | -155K | -2.68% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 6.67% | 0% | 12.9% |
| Revenue | 0% | -3.77% | 0% | 0.39% |